Literature DB >> 25456010

Histopathological grading of adenoid cystic carcinoma of the head and neck: analysis of currently used grading systems and proposal for a simplified grading scheme.

Stijn van Weert1, Isaäc van der Waal2, Birgit I Witte3, C René Leemans4, Elisabeth Bloemena2.   

Abstract

BACKGROUND: Histopathological grading of adenoid cystic carcinoma (ACC) is a controversial issue. It is generally agreed that solid type ACC has a relatively poor prognosis. However, the amount of solid regions within this often mixed type tumor that predicts a poor prognosis is not firmly established. Some authors stipulate that the presence of a solid component regardless of the amount is a poor prognosticator where others argue that the amount should be taken into consideration. Two grading systems most commonly used are those described by Perzin et al./Szanto et al. and Spiro et al., respectively. They report that prognosis of ACC is poor if >30% and >50% of the tumor volume has a solid growth pattern, respectively.
MATERIAL AND METHODS: The described grading systems are applied to a series of 81 surgically treated cases of ACC at the VU University Medical Center, Amsterdam, The Netherlands. Moreover, we introduced an alternative grading system, in which the presence of a solid component, irrespective of its amount, is considered. All three systems of grading were tested for inter-observer concordance and prediction of prognosis.
RESULTS: Inter-observer concordance for grading ACC according to Perzin et al./Szanto et al. and Spiro et al., proved to be moderate with Kappa Scores of 0.393 and 0.433, respectively. Our alternative grading system yielded inter-observer concordance with a Cohen's kappa result of 0.990. All systems were comparable in discriminating patients with poor clinical outcome. Histopathological grade proved to be an independent prognosticator.
CONCLUSION: The presence of any solid component in ACC is a negative prognosticator, and can histopathologically be diagnosed with a high reliability. These results suggest to merely register the presence or absence of a solid tumor component since its inter-observer variability is very low, its reproducibility is high and its predictive value is comparable to the traditional grading systems used.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenoid cystic carcinoma; Histopathological grading; Outcome; Reproducibility; Salivary gland; Survival

Mesh:

Year:  2014        PMID: 25456010     DOI: 10.1016/j.oraloncology.2014.10.007

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  24 in total

1.  Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands: A Clinicopathologic Study With Correlation Between MYB Fusion and Protein Expression.

Authors:  Bin Xu; Esther Drill; Allen Ho; Alan Ho; Lara Dunn; Carlos Nicolas Prieto-Granada; Timothy Chan; Ian Ganly; Ronald Ghossein; Nora Katabi
Journal:  Am J Surg Pathol       Date:  2017-10       Impact factor: 6.394

2.  Disparities in Postoperative Therapy for Salivary Gland Adenoid Cystic Carcinomas.

Authors:  Richard J Cassidy; Jeffrey M Switchenko; Mark W El-Deiry; Ryan H Belcher; Jim Zhong; Conor E Steuer; Nabil F Saba; Mark W McDonald; David S Yu; Theresa W Gillespie; Jonathan J Beitler
Journal:  Laryngoscope       Date:  2018-09-08       Impact factor: 3.325

Review 3.  Ceruminous Neoplasms of the Ear.

Authors:  Priyadharsini Nagarajan
Journal:  Head Neck Pathol       Date:  2018-08-01

4.  Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.

Authors:  Dipti P Sajed; William C Faquin; Chris Carey; Eric A Severson; Amir H Afrogheh; Carl A Johnson; Stephen C Blacklow; Nicole G Chau; Derrick T Lin; Jeffrey F Krane; Vickie Y Jo; Joaquín J Garcia; Lynette M Sholl; Jon C Aster
Journal:  Am J Surg Pathol       Date:  2017-11       Impact factor: 6.394

5.  World Health Organization 4th edition of head and neck tumor classification: insight into the consequential modifications.

Authors:  P J Slootweg; A K El-Naggar
Journal:  Virchows Arch       Date:  2018-02-15       Impact factor: 4.064

Review 6.  Ongoing challenges in the treatment of adenoid cystic carcinoma of the head and neck.

Authors:  T Subramaniam; P Lennon; J P O'Neill
Journal:  Ir J Med Sci       Date:  2015-04-17       Impact factor: 1.568

Review 7.  Diagnosis and management of malignant sublingual gland tumors: a narrative review.

Authors:  Minhae Park; Junhun Cho; Junsun Ryu; Han-Sin Jeong
Journal:  Gland Surg       Date:  2021-12

Review 8.  Beyond Surgical Treatment in Adenoid Cystic Carcinoma of the Head and Neck: A Literature Review.

Authors:  Sarah Atallah; Morgane Marc; Antoine Schernberg; Florence Huguet; Isabelle Wagner; Antti Mäkitie; Bertrand Baujat
Journal:  Cancer Manag Res       Date:  2022-06-04       Impact factor: 3.602

9.  Diagnostic discrepancy in second opinion reviews of primary epithelial neoplasms involving salivary gland: An 11-year experience from a tertiary referral center focusing on useful pathologic approaches and potential clinical impacts.

Authors:  Bin Xu; Ronald Ghossein; Alan Ho; Kartik Viswanathan; Anjanie Khimraj; Maelle Saliba; Jennifer R Cracchiolo; Nora Katabi
Journal:  Head Neck       Date:  2021-04-24       Impact factor: 3.821

10.  Prognostic Factors and Survival in Adenoid Cystic Carcinoma of the Head and Neck: A Retrospective Clinical and Histopathological Analysis of Patients Seen at a Cancer Center.

Authors:  Everton Freitas de Morais; Leorik Pereira da Silva; Deborah Gondim Lambert Moreira; Rodrigo Porpino Mafra; Larissa Santos Amaral Rolim; Edilmar de Moura Santos; Lélia Batista de Souza; Roseana de Almeida Freitas
Journal:  Head Neck Pathol       Date:  2020-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.